Christopher R. Lynch, Milan E. Folkers, William R. Hutson – 23 May 2006 – With data from the Women's Health Initiative indicating that estrogen plus progesterone are associated with an increased risk of cardiovascular events, many patients and practitioners are looking for alternative therapies to manage menopausal symptoms. One alternative is black cohosh, an herbal product used primarily to treat these symptoms. In recent years there have been several case reports associating this substance with hepatitis and fulminant hepatic failure.

Salleh Ibrahim, Chao‐Long Chen, Chih‐Che Lin, Chin‐Hsiang Yang, Chih‐Chi Wang, Shih‐Ho Wang, Yeuh‐Wei Liu, Chee‐Chien Yong, Allan Concejero, Bruno Jawan, Yu‐Fan Cheng – 23 May 2006 – Complications in a donor are a distressing but inevitable occurrence, since graft procurement is a major undertaking. Although the technique for procurement has some similarities to hepatic resection, a donor is very unlike a patient with malignancy. The risk factors identified in these patients cannot be extrapolated to donors.

Lunan Yan, Bo Li, Yong Zeng, Tianfu Wen, Jichun Zhao, Wentao Wang, Mingqing Xu, Jiayin Yang, Yukui Ma, Zheyu Chen, Hong Wu – 23 May 2006

Yasuhiko Sugawara, Masatoshi Makuuchi – 23 May 2006

Shin Hwang, Sung‐Gyu Lee, Kwang‐Min Park, Ki‐Hun Kim, Chul‐Soo Ahn, Heung‐Bum Oh, Deok‐Bog Moon, Tae‐Yong Ha, Young‐Suk Lim, Dong‐Hwan Jung – 23 May 2006 – The shortage of cadaveric donor organs has led to the use of living donors and marginal cadaveric donors. To date, there have been only 2 reports on the use of hepatitis B surface antigen (HBsAg)‐positive liver grafts. Here we describe the 5‐yr posttransplantation sequence of a hepatitis B virus (HBV)‐positive recipient who received an HBsAg‐positive living donor liver graft.

Thomas Heffron, David Welch, Todd Pillen, Massimo Asolati, Gregory Smallwood, Phil Hagedorn, Chang Nam, Alexander Duncan, Mark Guy, Enrique Martinez, James Spivey, Patricia Douglas, Carlos Fasola, Jill De Paolo, John Rodriguez, Rene Romero – 23 May 2006 – Transplanting blood group A, B, or O (ABO)‐incompatible (ABO‐I) liver grafts has resulted in lower patient and graft survival with an increased incidence of vascular and biliary complications and rejection.

23 May 2006 – Sponsors: Association française de chirurgie hépatobiliaire et de transplantation hépatique; and Association française pour l'étude du foie

Jayant A. Talwalkar – 23 May 2006

Jeong M. Park, Kathleen D. Lake, Robert J. Fontana – 23 May 2006

23 May 2006